What is Bicara Therapeutics's change in lease liabilities?

Bicara Therapeutics (BCAX) reported change in lease liabilities of -$270K in Q1 2026.

How has Bicara Therapeutics's change in lease liabilities changed year-over-year?

Bicara Therapeutics's change in lease liabilities decreased by 83.7% year-over-year, from -$147K to -$270K.

What does change in lease liabilities mean?

Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.

Bicara Therapeutics BCAX Change in Lease Liabilities

Change in Lease Liabilities at other companies

ArriVent BioPharma, Inc.AVBP

$47K+1,275%

ImmunomeIMNM

-$161K-160%

Vir Biotechnology, Inc.VIR

-$2.27M-26.6%

BridgeBio PharmaBBIO

-$1.85M-26.0%

Natera, Inc.NTRA

-$5.85M-29.9%

Aurinia PharmaceuticalsAUPH

-$214K-9.7%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.64B+81.4%

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's change in lease liabilities?: Bicara Therapeutics (BCAX) reported change in lease liabilities of -$270K in Q1 2026.
How has Bicara Therapeutics's change in lease liabilities changed year-over-year?: Bicara Therapeutics's change in lease liabilities decreased by 83.7% year-over-year, from -$147K to -$270K.
What does change in lease liabilities mean?: Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.